Abstract
Molecular heterogeneity of endothelial cells underlies their highly specialized functions during changing physiological conditions within diverse vascular beds. For example, placental spiral arteries (SAs) undergo remarkable remodeling to meet the ever-growing demands of the fetus — a process which is deficient in preeclampsia. The extent to which maternal endothelial cells coordinate with immune cells and pregnancy hormones to promote SA remodeling remains largely unknown. Here we found that remodeled SAs expressed the lymphatic markers PROX1, LYVE1, and VEGFR3, mimicking lymphatic identity. Uterine natural killer (uNK) cells, which are required for SA remodeling and secrete VEGFC, were both sufficient and necessary for VEGFR3 activation in vitro and in mice lacking uNK cells, respectively. Using Flt4Chy/+ mice with kinase inactive VEGFR3 and Vegfcfl/fl Vav1-Cre mice, we demonstrated that SA remodeling required VEGFR3 signaling, and that disrupted maternal VEGFR3 signaling contributed to late-gestation fetal growth restriction. Collectively, we identified a novel instance of lymphatic mimicry by which maternal endothelial cells promote SA remodeling, furthering our understanding of the vascular heterogeneity employed for the mitigation of pregnancy complications such as fetal growth restriction and preeclampsia.
Original language | English (US) |
---|---|
Pages (from-to) | 4912-4921 |
Number of pages | 10 |
Journal | Journal of Clinical Investigation |
Volume | 129 |
Issue number | 11 |
DOIs | |
State | Published - 2019 |
Funding
We thank Erika Wittchen, Brooke Matson, and Wenjing Xu for helpful comments and assistance with manuscript preparation, and Regan Scott for preparation of the rat tissue specimens used in the analysis. This project was supported by NIH grants R01 HD060860 (to KMC), HD020676 (to MJS), HD079363 (to MJS), HL073402 (to GO), HL120872 (to MLK), and F31 HD095585 (to JBP); Kirschstein-NRSA training grant T32 2T32HL069768-16 (to JBP); the Lendület program of the Hungarian Academy of Sciences (LP2014-4/2018 to ZJ); and the National Research, Development and Innovation Office (NVKP_16-2016-1-0039 to ZJ).
ASJC Scopus subject areas
- General Medicine